PATRICK HORNE: Open Payments
NPI 1487827960 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,711 in 64 payments from 9 companies in 2025. Trend: 2023 $4,028 · 2024 $12,919 · 2025 $25,711
Consulting: $18,506Travel & lodging: $2,869Food & beverage: $2,536Speaker / faculty: $1,800
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 21 | $9,529 |
| ABBVIE INC. | 12 | $5,131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $2,996 |
| GlaxoSmithKline, LLC. | 3 | $2,350 |
| Mirum Pharmaceuticals, Inc. | 5 | $1,552 |
| Ipsen Biopharmaceuticals, Inc | 6 | $1,520 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $1,264 |
| Intercept Pharmaceuticals, Inc. | 4 | $1,261 |
| Gilead Sciences, Inc. | 3 | $108 |
Products named: REZDIFFRA, MAVYRET, Livmarli, IQIRVO, OCALIVA, TRULANCE, XIFAXAN, Bylvay.
Industry payments across FL — which companies pay providers there.
